Keros Therapeutics Inc. (KROS)
NASDAQ · Healthcare
Keros Therapeutics Inc. Cash on Hand 2019–2025
Keros Therapeutics Inc. annual/quarterly cash on hand history from 2019 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Keros Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 287.4M, a 48.67% decrease year-over-year.
- Keros Therapeutics Inc. cash on hand for 2025 were 287.4M, a 48.67% decrease from 2024.
- Keros Therapeutics Inc. cash on hand for 2024 were 559.9M, a 69.09% increase from 2023.
- Keros Therapeutics Inc. cash on hand for 2023 were 331.1M, a 18.67% increase from 2022.
- Keros Therapeutics Inc. cash on hand for 2022 were 279.0M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Keros Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $287 |
| 2024 | $560 |
| 2023 | $331 |
| 2022 | $279 |
| 2021 | $230 |
| 2020 | $266 |
| 2019 | $7 |
| Keros Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $287 |
| 2024-12-31 | $560 |
| 2023-12-31 | $331 |
| 2022-12-31 | $279 |
| 2021-12-31 | $230 |
| 2020-12-31 | $266 |
| 2019-12-31 | $7 |
Keros Therapeutics Inc. Cash on Hand — FAQ
Keros Therapeutics Inc. (KROS) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KROS's cash on hand history?
The chart and table above show Keros Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.